Seminarios web
228 articles
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
Testing an Approved Drug for a Specific Mutation
Researchers are testing a drug combination for melanoma in pancreatic cancer patients with a BRAF genetic mutation.
Testing a Thyroid Cancer Drug to Treat Advanced Pancreatic Neuroendocrine Tumors
Researchers are testing a thyroid drug to see if it is effective against pancreatic neuroendocrine tumors, among other cancers.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver
Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?
New Gene Inhibitor Drug for Patients with MTAP-Deleted Tumors
A new trial targets patients with advanced solid tumors, including pancreatic cancer, with an MTAP-deletion genetic mutation.
Four-Drug Combination Tested in Metastatic Pancreatic Cancer
A clinical trial is testing a drug combination including a drug used for erectile dysfunction, a new drug, and two immunotherapy drugs.
My Journey with Pancreatic Cancer
Dr. Robert Wagar lost both parents to pancreatic cancer. When his wife found an article about a surveillance study he had an MRI, which found a lesion.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.
Hypertension Drug as Part of First-Line Treatment for Unresectable Pancreatic Cancer
Researchers are testing if the addition of a hypertension drug to standard treatment will be more effective for advanced pancreatic cancer.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Targeting Metabolic Vulnerability
Dr. Jordan Winter looks at cell metabolism to find areas of vulnerability in pancreatic cancer cells, to find a way to create better treatments.
Multi-Site Precision Promise Study Opens
Dr. Vincent Picozzi explains how Precision Promise clinical trial will use a personalized approach for pancreatic cancer patients.